234 related articles for article (PubMed ID: 32734556)
21. C-reactive protein correlates with computed tomographic findings and predicts severe COVID-19 early.
Tan C; Huang Y; Shi F; Tan K; Ma Q; Chen Y; Jiang X; Li X
J Med Virol; 2020 Jul; 92(7):856-862. PubMed ID: 32281668
[TBL] [Abstract][Full Text] [Related]
22. Epidemiology and clinical characteristics of 43 COVID-19 patients in Weifang, China.
Wang Q; Zheng S; Tan W; Qi L; Shao W; Zhang M; Sun X
Ann Palliat Med; 2020 Sep; 9(5):2993-2999. PubMed ID: 32819125
[TBL] [Abstract][Full Text] [Related]
23. Eosinopenia could be a relevant prognostic biomarker in patients with coronavirus disease 2019.
Perlini S; Ciprandi G; Castagnoli R; Licari A; Marseglia GL
Allergy Asthma Proc; 2020 Nov; 41(6):e80-e82. PubMed ID: 33109314
[No Abstract] [Full Text] [Related]
24. Association between incubation period and clinical characteristics of patients with COVID-19.
Cai Y; Liu J; Yang H; Wang M; Guo Q; Huang D; Yu Q; Xiao E
J Int Med Res; 2020 Sep; 48(9):300060520956834. PubMed ID: 32967488
[TBL] [Abstract][Full Text] [Related]
25. Liver damage at admission is an independent prognostic factor for COVID-19.
Chen LY; Chu HK; Bai T; Tu SJ; Wei Y; Li ZL; Hu LL; Zhu R; Zhang L; Han CQ; Xiao L; He Q; Song J; Liu WH; Zhu QJ; Chen H; Yang L; Hou XH
J Dig Dis; 2020 Sep; 21(9):512-518. PubMed ID: 32713118
[TBL] [Abstract][Full Text] [Related]
26. A Retrospective Study of the C-Reactive Protein to Lymphocyte Ratio and Disease Severity in 108 Patients with Early COVID-19 Pneumonia from January to March 2020 in Wuhan, China.
Yang M; Chen X; Xu Y
Med Sci Monit; 2020 Sep; 26():e926393. PubMed ID: 32914767
[TBL] [Abstract][Full Text] [Related]
27. Clinical characteristics of 71 patients with coronavirus disease 2019.
Xiao M; Hou M; Liu X; Li Z; Zhao Q
Zhong Nan Da Xue Xue Bao Yi Xue Ban; 2020 Jul; 45(7):790-796. PubMed ID: 32879082
[TBL] [Abstract][Full Text] [Related]
28. Clinical Characteristics of Patients with Severe Pneumonia Caused by the SARS-CoV-2 in Wuhan, China.
Wang Y; Zhou Y; Yang Z; Xia D; Hu Y; Geng S
Respiration; 2020; 99(8):649-657. PubMed ID: 32841948
[TBL] [Abstract][Full Text] [Related]
29. Clinical characteristics and the risk factors for severe events of elderly coronavirus disease 2019 patients.
Wang G; Wu C; Zhang Q; Yu B; LÜ J; Zhang S; Wu G; Wu Y; Zhong Y
Zhong Nan Da Xue Xue Bao Yi Xue Ban; 2020 May; 45(5):542-548. PubMed ID: 32879104
[TBL] [Abstract][Full Text] [Related]
30. Cardiovascular disease potentially contributes to the progression and poor prognosis of COVID-19.
Li M; Dong Y; Wang H; Guo W; Zhou H; Zhang Z; Tian C; Du K; Zhu R; Wang L; Zhao L; Fan H; Luo S; Hu D
Nutr Metab Cardiovasc Dis; 2020 Jun; 30(7):1061-1067. PubMed ID: 32456948
[TBL] [Abstract][Full Text] [Related]
31. Abnormal immunity of non-survivors with COVID-19: predictors for mortality.
Zhao Y; Nie HX; Hu K; Wu XJ; Zhang YT; Wang MM; Wang T; Zheng ZS; Li XC; Zeng SL
Infect Dis Poverty; 2020 Aug; 9(1):108. PubMed ID: 32746940
[TBL] [Abstract][Full Text] [Related]
32. Association of viral load with serum biomakers among COVID-19 cases.
Shi F; Wu T; Zhu X; Ge Y; Zeng X; Chi Y; Du X; Zhu L; Zhu F; Zhu B; Cui L; Wu B
Virology; 2020 Jul; 546():122-126. PubMed ID: 32452410
[TBL] [Abstract][Full Text] [Related]
33. Blood routine test in mild and common 2019 coronavirus (COVID-19) patients.
Djakpo DK; Wang Z; Zhang R; Chen X; Chen P; Antoine MMLK
Biosci Rep; 2020 Aug; 40(8):. PubMed ID: 32725148
[TBL] [Abstract][Full Text] [Related]
34. Value of dynamic clinical and biomarker data for mortality risk prediction in COVID-19: a multicentre retrospective cohort study.
Berzuini C; Hannan C; King A; Vail A; O'Leary C; Brough D; Galea J; Ogungbenro K; Wright M; Pathmanaban O; Hulme S; Allan S; Bernardinelli L; Patel HC
BMJ Open; 2020 Sep; 10(9):e041983. PubMed ID: 32967887
[TBL] [Abstract][Full Text] [Related]
35. Fasting blood glucose at admission is an independent predictor for 28-day mortality in patients with COVID-19 without previous diagnosis of diabetes: a multi-centre retrospective study.
Wang S; Ma P; Zhang S; Song S; Wang Z; Ma Y; Xu J; Wu F; Duan L; Yin Z; Luo H; Xiong N; Xu M; Zeng T; Jin Y
Diabetologia; 2020 Oct; 63(10):2102-2111. PubMed ID: 32647915
[TBL] [Abstract][Full Text] [Related]
36. Clinical features and treatment of COVID-19 patients in northeast Chongqing.
Wan S; Xiang Y; Fang W; Zheng Y; Li B; Hu Y; Lang C; Huang D; Sun Q; Xiong Y; Huang X; Lv J; Luo Y; Shen L; Yang H; Huang G; Yang R
J Med Virol; 2020 Jul; 92(7):797-806. PubMed ID: 32198776
[TBL] [Abstract][Full Text] [Related]
37. Prognostic value of interleukin-6, C-reactive protein, and procalcitonin in patients with COVID-19.
Liu F; Li L; Xu M; Wu J; Luo D; Zhu Y; Li B; Song X; Zhou X
J Clin Virol; 2020 Jun; 127():104370. PubMed ID: 32344321
[TBL] [Abstract][Full Text] [Related]
38. [Analysis of the clinical characteristics and early warning model construction of severe/critical coronavirus disease 2019 patients].
Xu J; Zhao F; Han M; Ma L; Zhang T
Zhonghua Wei Zhong Bing Ji Jiu Yi Xue; 2020 Apr; 32(4):401-406. PubMed ID: 32527341
[TBL] [Abstract][Full Text] [Related]
39. The diagnostic and predictive role of NLR, d-NLR and PLR in COVID-19 patients.
Yang AP; Liu JP; Tao WQ; Li HM
Int Immunopharmacol; 2020 Jul; 84():106504. PubMed ID: 32304994
[TBL] [Abstract][Full Text] [Related]
40. Clinical features of familial clustering in patients infected with 2019 novel coronavirus in Wuhan, China.
Li J; Gong X; Wang Z; Chen R; Li T; Zeng D; Li M
Virus Res; 2020 Sep; 286():198043. PubMed ID: 32502551
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
